– Hyundai Bioscience announcing the receipt of the phase 2 clinical study report of XaftyTM and its plans for the emergency use authorization – Planning fast track process in oversea countries to enter the global market SEOUL, South Korea, May 3, 2023 /PRNewswire/ — Hyundai Bioscience…
Month: May 2023
Restructuring Support Agreement Supported by Holders of More than 80% of the Company’s Senior Secured Notes and 100% of Holders of Second Lien Term Loan Restructuring Transactions Will Reduce the Company’s Funded Debt by Approximately $597 Million No Impact on Business Operations as…
– Hyundai Bioscience announcing the receipt of the phase 2 clinical study report of XaftyTM and its plans for the emergency use authorization – Planning fast track process in oversea countries to enter the global market SEOUL, South Korea, May 2, 2023 /PRNewswire/ — Hyundai Bioscience…
NEW YORK, May 2, 2023 /PRNewswire/ — The testosterone replacement therapy market size is forecast to increase by USD 439.67 million from 2022 to 2027, at a CAGR of 3.38%, according to the recent market study by Technavio. The growth of the market will be driven by the initiatives to…
NEW YORK, May 2, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, May 2, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Metropolitan Bank Holding Corp. (“MCB” or the “Company”) (NYSE: MCB). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, May 2, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Wolfspeed, Inc. (“Wolfspeed” or the “Company”) (NYSE: WOLF). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. pPon concerns…
NEW YORK, May 2, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Tilray Brands, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
VANCOUVER, BC, May 2, 2023 /PRNewswire/ — GameOn Entertainment Technologies Inc. (CSE: GET) (OTCQB: GMETF) (“GameOn” or the “Company”) announces that, further to its news release dated April 14, 2023 (the “Announcement”), its principal regulator, the British Columbia Securities…
NEW YORK, May 2, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Hesai Group (“Hesai” or the “Company”) (NASDAQ: HSAI). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation…